Protein tyrosine phosphatase receptor zeta 1 (PTPRZ1) is a type V transmembrane tyrosine
phosphatase that is highly expressed during embryonic development, while its expression …

Nanotechnology is transforming stem cell medicine by enabling precise isolation, controlled
differentiation, and targeted therapies across various medical domains. This review …

Hepatocellular carcinoma frequently recurs after surgery, necessitating personalized clinical
approaches based on tumor avatar models. However, location-dependent oxygen …

The control paradigm of small vessel pathophysiology has changed to focus on the vascular
out‐wall rather than the lumen‐intimal factors. As an emerging controller of the external wall …

Clinical translation of nanoparticles is limited because of their short circulation time, which
hampers targeting to prolong therapeutic effects. Angiogenesis is required to regenerate …

Protein tyrosine phosphatase receptor zeta 1 (PTPRZ1) is a transmembrane tyrosine
phosphatase (TP) expressed in endothelial cells and required for stimulation of cell …

Background Despite available treatment approaches, including surgical resection along with
chemotherapy and radiotherapy, glioblastoma (GBM), the most prevalent primary brain …

Background Glioblastoma (GBM), a primary malignant brain tumor, has a poor prognosis,
even with standard treatments such as radiotherapy and chemotherapy. In this study, we …

Cell-cell communication serves as a foundation concept of intercellular therapeutic hand-
over. Despite the commonsense level of understanding, no clear projection has been made …

As hepatocellular carcinoma (HCC) recurs even after surgical operation, tumor avatar
models have been suggested to approach the HCC type-specified clinical strategy …